Home Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory
Article
Licensed
Unlicensed Requires Authentication

Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory

  • Gurdeep S. Dhatt , Mukesh M. Agarwal , Bassam Bishawi and Janice Gill
Published/Copyright: April 1, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 4

Abstract

Background: Analytical performance of clinical laboratory testing should be evaluated against objective quality specifications. The Stockholm Conference consensus recommendation states that from a hierarchy of quality models, the highest-ranking model should be used. This study reports the performance of a routine clinical laboratory using these quality recommendations. Quality standards recommended for use in manufacturers' package inserts are also compared against the objective criteria.

Methods: Imprecision of 22 analytes was monitored by analyzing three levels of commercial quality control (QC) material daily over a 6-month period. The performance for each analyte was evaluated against defined quality specifications based on biological variation and the National Cholesterol Education Panel (NCEP) criteria.

Results: Overall, objective quality specifications were met by the laboratory for 18/22 (82%) analytes. The performance for analytes not meeting the criteria was assessed against quality targets based on a model lower in the hierarchy, i.e., interlaboratory imprecision data derived from an accredited EQA program. All analytes met these quality targets. When quality targets set by the manufacturer were applied to biological variation and NCEP criteria, results for only 8/22 (36 %) analytes met the targets.

Conclusions: Objective quality specifications can be consistently achieved in a routine laboratory. The hierarchy model of the Stockholm Conference should be promoted for global adoption.

Clin Chem Lab Med 2007;45:549–;52.


Corresponding author: Dr. Gurdeep Singh Dhatt, Department of Pathology and Laboratory Medicine, Tawam Hospital, P.O. Box 15258, Al Ain, United Arab Emirates Phone: +971-3-7072417, Fax: +971-3-7072418,

Received: 2006-11-14
Accepted: 2007-1-8
Published Online: 2007-04-01
Published in Print: 2007-04-01

© 2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations
  2. Haemophilia A: molecular insights
  3. Quality specifications: self pleasure for clinical laboratories or added value for patient management?
  4. A724A polymorphism of sarco(endo)plasmic reticulum Ca2+-ATPase 2 (SERCA2) in hypertensive patients
  5. Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk
  6. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population
  7. A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency
  8. The c.–292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective
  9. The genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients
  10. Diagnostic performance of combined specific urinary proteins and urinary flow cytometry in urinary tract pathology
  11. Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases
  12. Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials
  13. Free serum cortisol: quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system
  14. Percutaneous coronary intervention-induced variations in systemic parameters of inflammation: relationship with the mode of stenting
  15. Multicentre physiological reference values for the concentration of creatininium in plasma and diagnostic specificity of glomerular filtration rate estimated with the MDRD equation
  16. Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia
  17. Reference intervals for follicle-stimulating hormone, luteinizing hormone and prolactin in children and young adults on the bioMérieux Mini-Vidas system
  18. Limits of usual biochemical alcohol markers in cord blood at term: a fetal/maternal population-based study
  19. Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory
  20. The diffusion of innovations theory could help laboratorians in research translation
  21. Detection of CYP2D6 polymorphisms *9, *10, and *41 using ARMS-PCR and their allelic frequencies in 400 psychiatric patients
  22. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method
  23. Measurement of free thyroxine in laboratory medicine – proposal of measurand definition
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.105/html
Scroll to top button